Suppr超能文献

生物材料介导的免疫系统工程

Biomaterials-Mediated Engineering of the Immune System.

机构信息

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; email:

Departments of Biological Engineering and Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

出版信息

Annu Rev Immunol. 2023 Apr 26;41:153-179. doi: 10.1146/annurev-immunol-101721-040259. Epub 2023 Jan 25.

Abstract

Modulation of the immune system is an important therapeutic strategy in a wide range of diseases, and is fundamental to the development of vaccines. However, optimally safe and effective immunotherapy requires precision in the delivery of stimulatory cues to the right cells at the right place and time, to avoid toxic overstimulation in healthy tissues or incorrect programming of the immune response. To this end, biomaterials are being developed to control the location, dose, and timing of vaccines and immunotherapies. Here we discuss fundamental concepts of how biomaterials are used to enhance immune modulation, and evidence from preclinical and clinical studies of how biomaterials-mediated immune engineering can impact the development of new therapeutics. We focus on immunological mechanisms of action and in vivo modulation of the immune system, and we also discuss challenges to be overcome to speed translation of these technologies to the clinic.

摘要

免疫系统的调节是广泛疾病治疗的重要策略,也是疫苗发展的基础。然而,为了实现最佳的安全性和有效性,免疫疗法需要精确地将刺激信号递送到正确的细胞,在正确的位置和时间,以避免在健康组织中产生毒性的过度刺激或免疫反应的错误编程。为此,正在开发生物材料来控制疫苗和免疫疗法的位置、剂量和时间。在这里,我们讨论了生物材料如何用于增强免疫调节的基本概念,以及临床前和临床研究中生物材料介导的免疫工程如何影响新疗法的发展的证据。我们重点讨论了免疫作用机制和体内免疫系统的调节,还讨论了为加快这些技术向临床转化而需要克服的挑战。

相似文献

1
Biomaterials-Mediated Engineering of the Immune System.
Annu Rev Immunol. 2023 Apr 26;41:153-179. doi: 10.1146/annurev-immunol-101721-040259. Epub 2023 Jan 25.
2
Advances in immunotherapy delivery from implantable and injectable biomaterials.
Acta Biomater. 2019 Apr 1;88:15-31. doi: 10.1016/j.actbio.2019.02.016. Epub 2019 Feb 13.
3
Harnessing Biomaterials to Study and Direct Antigen-Specific Immunotherapy.
ACS Appl Bio Mater. 2023 Jun 19;6(6):2017-2028. doi: 10.1021/acsabm.3c00136. Epub 2023 Apr 17.
4
Advanced Biomaterials for Cell-Specific Modulation and Restore of Cancer Immunotherapy.
Adv Sci (Weinh). 2022 May;9(16):e2200027. doi: 10.1002/advs.202200027. Epub 2022 Mar 27.
5
Improving the clinical impact of biomaterials in cancer immunotherapy.
Oncotarget. 2016 Mar 29;7(13):15421-43. doi: 10.18632/oncotarget.7304.
6
Biomaterials as Tools to Decode Immunity.
Adv Mater. 2020 Apr;32(13):e1903367. doi: 10.1002/adma.201903367. Epub 2019 Nov 29.
7
Radiotherapy combined with nano-biomaterials for cancer radio-immunotherapy.
J Nanobiotechnology. 2023 Oct 30;21(1):395. doi: 10.1186/s12951-023-02152-2.
8
Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines.
Trends Biotechnol. 2011 Jun;29(6):294-306. doi: 10.1016/j.tibtech.2011.02.004. Epub 2011 Apr 2.
9
Engineering vaccines and niches for immune modulation.
Acta Biomater. 2014 Apr;10(4):1728-40. doi: 10.1016/j.actbio.2013.12.036. Epub 2013 Dec 27.
10
Engineering Immune Tolerance with Biomaterials.
Adv Healthc Mater. 2019 Feb;8(4):e1801419. doi: 10.1002/adhm.201801419. Epub 2019 Jan 3.

引用本文的文献

2
Advances in molecular pathology and therapy of non-small cell lung cancer.
Signal Transduct Target Ther. 2025 Jun 15;10(1):186. doi: 10.1038/s41392-025-02243-6.
3
Diverse priming outcomes under conditions of very rare precursor B cells.
Immunity. 2025 Apr 8;58(4):997-1014.e11. doi: 10.1016/j.immuni.2025.03.003. Epub 2025 Mar 31.
4
Leveraging tissue-resident memory T cells for non-invasive immune monitoring via microneedle skin patches.
medRxiv. 2025 Mar 21:2025.03.17.25324099. doi: 10.1101/2025.03.17.25324099.
5
Modulating Neutrophil Extracellular Trap Formation with Locoregional Precision Using Differently Charged Self-Assembled Hydrogels.
ACS Cent Sci. 2025 Mar 12;11(3):465-478. doi: 10.1021/acscentsci.4c02198. eCollection 2025 Mar 26.
6
Cell-Instructive Biomaterials with Native-Like Biochemical Complexity.
Annu Rev Biomed Eng. 2025 May;27(1):185-209. doi: 10.1146/annurev-bioeng-120823-020209. Epub 2025 Jan 28.
7
Recombinant fibrous protein biomaterials meet skin tissue engineering.
Front Bioeng Biotechnol. 2024 Aug 14;12:1411550. doi: 10.3389/fbioe.2024.1411550. eCollection 2024.
8
Tailoring biomaterials for vaccine delivery.
J Nanobiotechnology. 2024 Aug 12;22(1):480. doi: 10.1186/s12951-024-02758-0.
10
A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy.
Mol Cancer. 2024 Jun 1;23(1):117. doi: 10.1186/s12943-024-02032-9.

本文引用的文献

2
Long-primed germinal centres with enduring affinity maturation and clonal migration.
Nature. 2022 Sep;609(7929):998-1004. doi: 10.1038/s41586-022-05216-9. Epub 2022 Sep 21.
6
Landscape of cancer cell therapies: trends and real-world data.
Nat Rev Drug Discov. 2022 Sep;21(9):631-632. doi: 10.1038/d41573-022-00095-1.
7
STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity.
Nat Mater. 2022 Jun;21(6):710-720. doi: 10.1038/s41563-022-01251-z. Epub 2022 May 23.
8
Engineered cellular immunotherapies in cancer and beyond.
Nat Med. 2022 Apr;28(4):678-689. doi: 10.1038/s41591-022-01765-8. Epub 2022 Apr 19.
9
Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells.
Nat Biotechnol. 2022 Aug;40(8):1250-1258. doi: 10.1038/s41587-022-01245-x. Epub 2022 Mar 24.
10
IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.
Nat Immunol. 2022 Apr;23(4):532-542. doi: 10.1038/s41590-022-01160-y. Epub 2022 Mar 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验